https://www.selleckchem.com/pr....oducts/elsubrutinib.
The reference standard was surgical pathologic findings. MRI revealed 93 accompanying NME lesions in 92 (19.5%) of the 471 patients, showing 55 (59.1%) malignant and 38 (40.9%) benign lesions. On multivariate analysis, malignant NME lesions were more associated with mammography-positive findings ( = 0.00, clumped or clustered ring internal enhancement ( = 0.015), and extensive intraductal component presence of index tumor ( = 0.007) compared with benign lesions. The AUC increased after correlation with mammography showing 0.64
Me gusta
Comentario
Compartir
